Transconjunctival Versus Transcutaneous Betamethasone for Upper Eyelid Retraction in TED

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This randomized controlled trial aims to compare the efficacy and safety of transconjunctival versus transcutaneous perilevator betamethasone injection in reducing upper eyelid retraction in patients with thyroid eye disease.
Epistemonikos ID: 6c2e675898554063f242811bd6ddfe627b30f04a
First added on: Oct 09, 2026